| Name | Title | Contact Details |
|---|
Brightline is the first full-family behavioral health solution built specifically to care for kids, teens, and parents across a range of common family challenges. Launched at a time when 1 in 5 children has a behavioral health condition and up to 80% don't get the care they need, with increasing need exacerbated by the Covid-19 pandemic, Brightline is here to help families across the country thrive. With multidisciplinary care teams, personalized family system care, evidence-based care delivery, and extraordinary technology, Brightline is able to support families with whatever challenges they’re facing and ultimately help them thrive long-term. With Brightline, families can access support for a range of needs with our digital platform that includes resources and education for parents, interactive treatment exercises, and more; 1:1 coaching to support kids, teens, and parents with skill-building and guidance for dealing with tough stuff; behavior therapy, medication support, and speech therapy for a range of behavioral and developmental health needs. All right from home, right when families need it most. Join us to bring extraordinary care to families across the country!
Alternative Resources Company is a Valhalla, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live microbial biotherapeutic candidates with Assembly`s fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. We pride ourselves on creating a culture and work environment that is scientifically driven, ambitious, and collaborative. We encourage diversity of thought that leads to great innovation and are looking to add to our dynamic team great people who are driven to transform the lives of patients. We believe our Microbiome platform represents a best in class approach to developing biopharmaceutical agents from live biotherapeutic products. ABI-M201, our lead program in mildly to moderately active ulcerative colitis (UC), is currently in a phase 1b clinical trial. This program is part of a broader collaboration we established with Allergan in 2017 for gastrointestinal programs such as UC, Crohn`s disease and Irritable Bowel Syndromes with potential total development and commercial milestones of up to $2.8 billion. Our internal pipeline comprises first in class or best in class live microbial biotherapeutic approaches in areas such as oncology, immune mediated and metabolic disorders, and other areas of high medical need. Assembly is headquartered in Carmel, Indiana, while the R&D headquarters is in South San Francisco. The Company also has a microbiome manufacturing facility in Groton, CT, and offices in China.
Hartford Neurology is a Bloomfield, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.